Interestingly, in neuroendocrine lung cancer, heterogeneous expression of Pax5 has been reported with the highest in the small-cell (SCLC) subtype, followed by large cell and carcinoid [93]. The gene discussed is PAX5; the disease is carcinoid tumor.